The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
Mouse and human dendritic cell subtypes
Shortman, K., & Liu, Y.-J. (2002) · Nature Reviews Immunology · doi:10.1038/nri746 · Cited by 2,291
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Novel Signal Transduction Pathway Utilized by Extracellular HSP70
Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Baré, O., Auron, P. E., Stevenson, M. A., & Calderwood, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200497200 · Cited by 1,510
Cooperation of Toll-like receptor signals in innate immune defence
Trinchieri, G., & Sher, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2038 · Cited by 1,364
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E., Nilsen, N. J., Espevik, T., & Golenbock, D. T. (2004) · Nature Immunology · doi:10.1038/ni1028 · Cited by 1,361
Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D. W., & Schmitz, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6037 · Cited by 1,298
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Gilliet, M., Cao, W., & Liu, Y.-J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2358 · Cited by 1,190
Muzio, M., Bosisio, D., Polentarutti, N., D’amico, G., Stoppacciaro, A., Mancinelli, R., van’t Veer, C., Penton-Rol, G., Ruco, L. P., Allavena, P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5998 · Cited by 1,060
TLR11 Activation of Dendritic Cells by a Protozoan Profilin-Like Protein
Yarovinsky, F., Zhang, D., Andersen, J. F., Bannenberg, G. L., Serhan, C. N., Hayden, M. S., Hieny, S., Sutterwala, F. S., Flavell, R. A., Ghosh, S., et al. (2005) · Science · doi:10.1126/science.1109893 · Cited by 1,048
A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria
Zhang, D., Zhang, G., Hayden, M. S., Greenblatt, M. B., Bussey, C., Flavell, R. A., & Ghosh, S. (2004) · Science · doi:10.1126/science.1094351 · Cited by 1,004
Dendritic cell immunotherapy: mapping the way
Figdor, C. G., de Vries, I. J. M., Lesterhuis, W. J., & Melief, C. J. M. (2004) · Nature Medicine · doi:10.1038/nm1039 · Cited by 945
Self-citationBanchereau, J., Palucka, A. K., Dhodapkar, M. V., Burkeholder, S. B., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K. M., Bhardwaj, N., et al. (2001) · PubMed · Cited by 806
Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., & Lanzavecchia, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3388::aid-immu3388>3.0.co;2-q · Cited by 788
Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A. M., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3026::aid-immu3026>3.0.co;2-h · Cited by 786
Characterization of human blood dendritic cell subsets
MacDonald, K. P. A., Munster, D. J., Clark, G. J., Dzionek, A., Schmitz, J., & Hart, D. N. J. (2002) · Blood · doi:10.1182/blood-2001-11-0097 · Cited by 758
Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells
Matsumoto, M., Funami, K., Tanabe, M., Oshiumi, H., Shingai, M., Seto, Y., Yamamoto, A., & Seya, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3154 · Cited by 707
Zou, W., Machelon, V., Coulomb-L'Hermin, A., Borvak, J., Nome, F., Isaeva, T., Wei, S., Krzysiek, R., Durand-Gasselin, I., Gordon, A., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1339 · Cited by 653
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G.-P., Chapman, H. A., & Barton, G. M. (2008) · Nature · doi:10.1038/nature07405 · Cited by 617
Regulation of Toll-Like Receptors in Human Monocytes and Dendritic Cells
Visintin, A., Mazzoni, A., Spitzer, J. H., Wyllie, D. H., Dower, S. K., & Segal, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.249 · Cited by 612
Karsunky, H., Merad, M., Cozzio, A., Weissman, I. L., & Manz, M. G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030323 · Cited by 602
Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., & Blay, J. Y. (1998) · Blood · doi:10.1182/blood.v92.12.4778 · Cited by 590
Boonstra, A., Asselin-Paturel, C., Gilliet, M., Crain, C., Trinchieri, G., Liu, Y.-J., & O'Garra, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021908 · Cited by 551
Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A., & Banchereau, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1417 · Cited by 544
Vabulas, R. M., Braedel, S., Hilf, N., Singh-Jasuja, H., Herter, S., Ahmad-Nejad, P., Kirschning, C. J., da Costa, C., Rammensee, H.-G., Wagner, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200425200 · Cited by 488
Ito, T., Amakawa, R., Kaisho, T., Hemmi, H., Tajima, K., Uehira, K., Ozaki, Y., Tomizawa, H., Akira, S., & Fukuhara, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020207 · Cited by 466
Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer
Treilleux, I., Blay, J.-Y., Bendriss-Vermare, N., Ray-Coquard, I., Bachelot, T., Guastalla, J.-P., Bremond, A., Goddard, S., Pin, J.-J., Barthelemy-Dubois, C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0684 · Cited by 460
Hochrein, H., Schlatter, B., O'Keeffe, M., Wagner, C., Schmitz, F., Schiemann, M., Bauer, S., Suter, M., & Wagner, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403555101 · Cited by 439
Hasan, U., Chaffois, C., Gaillard, C., Saulnier, V., Merck, E., Tancredi, S., Guiet, C., Brière, F., Vlach, J., Lebecque, S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2942 · Cited by 435
Decreased antigen presentation by dendritic cells in patients with breast cancer.
Gabrilovich, D. I., Corak, J., Ciernik, I. F., Kavanaugh, D., & Carbone, D. P. (1997) · PubMed · Cited by 429
Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug
Miller, R. L., Gerster, J. F., Owens, M. L., Slade, H. B., & Tomai, M. A. (1999) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(98)00068-x · Cited by 417
Means, T. K., Hayashi, F., Smith, K. D., Aderem, A., & Luster, A. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5165 · Cited by 410
Guiducci, C., Ott, G., Chan, J. H., Damon, E., Calacsan, C., Matray, T., Lee, K.-D., Coffman, R. L., & Barrat, F. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060401 · Cited by 391
D'Amico, A., & Wu, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030107 · Cited by 386
Plasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma
Wei, S., Kryczek, I., Zou, L., Daniel, B., Cheng, P., Mottram, P., Curiel, T., Lange, A., & Zou, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4043 · Cited by 379
Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors
Chuang, T.-H., & Ulevitch, R. J. (2004) · Nature Immunology · doi:10.1038/ni1066 · Cited by 374
Most lymphoid organ dendritic cell types are phenotypically and functionally immature
Wilson, N. S., El-Sukkari, D., Belz, G. T., Smith, C. M., Steptoe, R. J., Heath, W. R., Shortman, K., & Villadangos, J. A. (2003) · Blood · doi:10.1182/blood-2003-02-0513 · Cited by 358
Hartmann, E., Wollenberg, B., Rothenfußer, S., Wagner, M., Wellisch, D., Mack, B., Giese, T., Gires, O., Endres, S., & Hartmann, G. (2003) · PubMed · Cited by 332
de Vries, I. J. M., Lesterhuis, W. J., Scharenborg, N. M., Engelen, L. P. H., Ruiter, D. J., Gerritsen, M. P., Croockewit, S., Britten, C. M., Torensma, R., Adema, G. J., et al. (2003) · PubMed · Cited by 327
Self-citationHuysamen, C., Willment, J. A., Dennehy, K. M., & Brown, G. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709923200 · Cited by 318
Flacher, V., Bouschbacher, M., Verronèse, E., Massacrier, C., Sisirak, V., Berthier-Vergnes, O., de Saint-Vis, B., Caux, C., Dezutter-Dambuyant, C., Lebecque, S., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7959 · Cited by 268
Osugi, Y., Vuckovic, S., & Hart, D. N. J. (2002) · Blood · doi:10.1182/blood.v100.8.2858 · Cited by 216
Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets
Piccioli, D., Tavarini, S., Borgogni, E., Steri, V., Nuti, S., Sammicheli, C., Bardelli, M., Montagna, D., Locatelli, F., & Wack, A. (2007) · Blood · doi:10.1182/blood-2006-08-038422 · Cited by 211
The Lymphoid Past of Mouse Plasmacytoid Cells and Thymic Dendritic Cells
Corcoran, L., Ferrero, I., Vremec, D., Lucas, K., Waithman, J., O’Keeffe, M., Wu, L., Wilson, A., & Shortman, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4926 · Cited by 206
Salio, M., Cella, M., Vermi, W., Facchetti, F., Palmowski, M. J., Smith, C. L., Shepherd, D., Colonna, M., & Cerundolo, V. (2003) · European Journal of Immunology · doi:10.1002/eji.200323676 · Cited by 198
Lindstedt, M., Lundberg, K., & Borrebaeck, C. A. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.4839 · Cited by 185
Bonehill, A., Tuyaerts, S., Van Nuffel, A. M., Heirman, C., Bos, T. J., Fostier, K., Neyns, B., & Thielemans, K. (2008) · Molecular Therapy · doi:10.1038/mt.2008.77 · Cited by 185
From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias
Netea, M. G., Van der Meer, J. W. M., Sutmuller, R. P., Adema, G. J., & Kullberg, B.-J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.3991-3996.2005 · Cited by 179
Self-citationHofmann, M. A., Kors, C., Audring, H., Walden, P., Sterry, W., & Trefzer, U. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318174a4df · Cited by 153
Schäkel, K., Mayer, E., Federle, C., Schmitz, M., Riethmüller, G., & Rieber, E. P. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199812)28:12<4084::aid-immu4084>3.0.co;2-4 · Cited by 152
TLR Activation of Langerhans Cell-Like Dendritic Cells Triggers an Antiviral Immune Response
Renn, C. N., Sanchez, D. J., Ochoa, M. T., Legaspi, A. J., Oh, C., Liu, P. T., Krutzik, S. R., Sieling, P. A., Cheng, G., & Modlin, R. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.298 · Cited by 140
Hovanessian, A. G. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.003 · Cited by 136
TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA
Chockalingam, A., Brooks, J. C., Cameron, J. L., Blum, L. K., & Leifer, C. A. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.101 · Cited by 135
Lou, Y., Liu, C., Kim, G. J., Liu, Y., Hwu, P., & Wang, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1534 · Cited by 134
Dendritic cell vaccines in melanoma: From promise to proof?
Lesterhuis, W. J., Aarntzen, E. H. J. G., de Vries, I. J. M., Schuurhuis, D. H., Figdor, C. G., Adema, G. J., & Punt, C. J. A. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.12.007 · Cited by 124
Self-citationJefford, M., Schnurr, M. M., Toy, T., Masterman, K., Shin, A., Beecroft, T., Tai, T. Y., Shortman, K., Shackleton, M. J., Davis, I. D., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3854 · Cited by 110
Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes
Kokkinopoulos, I., Jordan, W. J., & Ritter, M. A. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.09.037 · Cited by 106
Piccioli, D., Sammicheli, C., Tavarini, S., Nuti, S., Frigimelica, E., Manetti, A. G. O., Nuccitelli, A., Aprea, S., Valentini, S. B., Borgogni, E., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186890 · Cited by 86
Imiquimod in basal cell carcinoma: how does it work?
Dummer, R., Urosevic, M., Kempf, W., Hoek, K. S., Hafner, J., & Burg, G. (2003) · British Journal of Dermatology · doi:10.1046/j.0366-077x.2003.05630.x · Cited by 78
Soruri, A., Kiafard, Z., Dettmer, C., Riggert, J., Köhl, J., & Zwirner, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3306 · Cited by 65
Toll-Like Receptors (TLRs) and Innate Immunity
Bauer, S., & Hartmann, G. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72167-3 · Cited by 64
Lesterhuis, W. J., de Vries, I. J. M., Adema, G. J., & Punt, C. J. A. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh919 · Cited by 60
Self-citationForkhead Box P3 Regulates TLR10 Expression in Human T Regulatory Cells
Bell, M. P., Svingen, P. A., Rahman, M. K., Xiong, Y., & Faubion, W. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1893 · Cited by 58
Dendritic Cell Subsets and Toll-Like Receptors
Hochrein, H., & O’Keeffe, M. A. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72167-3_8 · Cited by 42
Cited by
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Sharma, P., Wagner, K., Wolchok, J. D., & Allison, J. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3153 · Cited by 642
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Heras-Murillo, I., Adán-Barrientos, I., Galán, M., Wculek, S. K., & Sancho, D. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00859-1 · Cited by 383
Dendritic Cell–Based Immunotherapy: State of the Art and Beyond
Bol, K. F., Schreibelt, G., Gerritsen, W. R., de Vries, I. J. M., & Figdor, C. G. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1399 · Cited by 377
Self-citationIntegrating next-generation dendritic cell vaccines into the current cancer immunotherapy landscape
Garg, A. D., Coulie, P. G., Van den Eynde, B. J., & Agostinis, P. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.05.006 · Cited by 340
Metadata
- Authors
- Schreibelt, G., Tel, J., Sliepen, K. H. E. W. J., Benitez-Ribas, D., Figdor, C. G., Adema, G. J., & de Vries, I. J. M.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2010-03-05
- Volume
- 59
- Issue
- 10
- Pages
- 1573-1582
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W2094158049
- Cited by
- 272
- References
- 71
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.